US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neurosense Therapeutics Ltd

1.00

+0.01311.32%

Post-market: 1.010.0100+1.00%17:23 EDT

Volume:118.59K

Turnover:118.33K

Market Cap:23.99M

PE:-1.82

High:1.02

Open:1.02

Low:0.9600

Close:0.9869

Loading ...

Overview Company News Filings

NeuroSense Therapeutics 9-Month EPS $(0.48) Up From $(0.55) YoY

Neurosense Therapeutics 9M EPS USD -0.48

THOMSON REUTERS

Press Release: NeuroSense Provides Business Update and Third Quarter 2024 Financial Results

Neurosense Therapeutics Ltd : Maxim Group Cuts to Hold From Buy

THOMSON REUTERS

NeuroSense downgraded to Hold from Buy at Maxim

NeuroSense concludes Type C meeting with FDA for PrimeC treatment

BRIEF-Neurosense Receives Positive FDA Feedback On Phase 3 Study Design For Primec

Neurosense Receives Positive FDA Feedback on Phase 3 Study Design for Primec

THOMSON REUTERS

Neurosense Therapeutics Ltd: Plans to Submit Final Protocol to FDA During First Half of 2025

THOMSON REUTERS

NeuroSense Receives Positive FDA Feedback on Phase 3 Study Design for PrimeC

Rimon Gold Assets Ltd. Reports 9.99% Passive Stake in Neurosense Therapeutics Ltd as of Dec 2 - SEC Filing

THOMSON REUTERS

NeuroSense Therapeutics Files Prospectus for Secondary Stock Sale

MT Newswires Live

NeuroSense’s PrimeC Shows Promise in ALS Treatment

NeuroSense announces ‘positive’ results from the PARADIGM study

NeuroSense Announces Completion of PARADIGM Study Highlighting PrimeC's Significant Efficacy and Survival Benefits in ALS

Neurosense Therapeutics Announces $5 Million Private Placement at Premium to Market Price

THOMSON REUTERS

Press Release: NeuroSense Therapeutics Announces $5 Million Private Placement at Premium to Market Price

NeuroSense Therapeutics to Participate in the 2024 International Symposium on ALS/MND

BRIEF-Neurosense Therapeutics Files For Offering Of Up To 10 Million Ordinary Shares

Neurosense Therapeutics Ltd Files for Offering of up to 10 Mln Ordinary Shares

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NRSN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NRSN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRSN\",,,,,undefined,":{"symbol":"NRSN","market":"US","secType":"STK","nameCN":"Neurosense Therapeutics Ltd","latestPrice":1,"timestamp":1745524800000,"preClose":0.986947,"halted":0,"volume":118594,"hourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1,"latestTime":"17:23 EDT","volume":108,"amount":105.0199992,"timestamp":1745529828185},"delay":0,"floatShares":11925112,"shares":23988669,"eps":-0.548863,"marketStatus":"Post-Mkt","change":0.013053,"latestTime":"04-24 19:00:16 EDT","open":1.02,"high":1.02,"low":0.96,"amount":118329.6361849,"amplitude":0.060794,"askPrice":1.04,"askSize":102,"bidPrice":0.96,"bidSize":330,"shortable":3,"etf":0,"ttmEps":-0.548863,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745539200000},"marketStatusCode":4,"adr":0,"listingDate":1639026000000,"exchange":"NASDAQ","adjPreClose":0.986947,"preHourTrading":{"tag":"盘前","latestPrice":1.0194,"preClose":0.9754,"latestTime":"09:27 EDT","volume":917,"amount":939.7407747000001,"timestamp":1745501247923},"postHourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1,"latestTime":"17:23 EDT","volume":108,"amount":105.0199992,"timestamp":1745529828185},"volumeRatio":1.306452},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRSN\",,,,,undefined,":{"symbol":"NRSN","floatShares":11925112,"roa":"-159.50%","roe":"-2478.16%","lyrEps":-0.548863,"volumeRatio":1.306452,"shares":23988669,"dividePrice":0,"high":1.02,"amplitude":0.060794,"preClose":0.986947,"low":0.96,"week52Low":0.512,"pbRate":"9.29","week52High":1.5,"institutionHeld":0,"latestPrice":1,"committee":0.527778,"eps":-0.548863,"divideRate":0,"volume":118594,"delay":0,"ttmEps":-0.548863,"open":1.02,"prevYearClose":1.2,"prevWeekClose":1.0333,"prevMonthClose":0.9299,"prevQuarterClose":0.9299,"fiveDayClose":1.031,"twentyDayClose":1.0868,"sixtyDayClose":1.04},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NRSN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2492180810","title":"NeuroSense Therapeutics 9-Month EPS $(0.48) Up From $(0.55) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2492180810","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492180810?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:35","pubTimestamp":1734536106,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics 9-Month EPS $(0.48) Up From $(0.55) YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/12/42556516/neurosense-therapeutics-9-month-eps-0-48-up-from-0-55-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","LENZ"],"gpt_icon":0},{"id":"2492187164","title":"Neurosense Therapeutics 9M EPS USD -0.48","url":"https://stock-news.laohu8.com/highlight/detail?id=2492187164","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492187164?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:26","pubTimestamp":1734535561,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nPLX6B41D9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2492187131","title":"Press Release: NeuroSense Provides Business Update and Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2492187131","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492187131?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:26","pubTimestamp":1734535560,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Dec. 18, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd.  , a late-stage clinical biotechnology company developing novel treatments for severe neurodegenerative diseases, today provided business update with corporate highlights to date and third quarter financial results.\"The completion of the 18-month Phase 2b PARADIGM study was a major milestone for NeuroSense. The results highlight PrimeC's potential impact on slowing disease progression and survival benefits in people living with ALS. Furthermore, the positive feedback from a Type C meeting with the FDA on the pivotal study design has the Company on track to commence a Phase 3 study in mid-2025. In parallel, the Company is taking steps toward early commercialization in Canada, with an anticipated potential launch in 2026, bringing us closer to delivering a much-needed solution to the ALS community,\" stated Alon Ben-Noon, CEO of NeuroSense.In December 2024, NeuroSense announced a $5 million private placement at p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2491693785","title":"Neurosense Therapeutics Ltd : Maxim Group Cuts to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2491693785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491693785?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:05","pubTimestamp":1734354336,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NH117:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2491069386","title":"NeuroSense downgraded to Hold from Buy at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2491069386","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491069386?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:41","pubTimestamp":1734352865,"startTime":"0","endTime":"0","summary":"Maxim downgraded NeuroSense (NRSN) to Hold from Buy. Published first on TheFly – the ultimate source for real-time, market-moving breaking financia...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurosense-downgraded-to-hold-from-buy-at-maxim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurosense-downgraded-to-hold-from-buy-at-maxim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2490863748","title":"NeuroSense concludes Type C meeting with FDA for PrimeC treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2490863748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490863748?lang=en_us&edition=fundamental","pubTime":"2024-12-11 22:30","pubTimestamp":1733927418,"startTime":"0","endTime":"0","summary":"NeuroSense (NRSN) Therapeutics announced it has concluded a Type C meeting with the FDA for PrimeC in the treatment of amyotrophic lateral sclerosi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurosense-concludes-type-c-meeting-with-fda-for-primec-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurosense-concludes-type-c-meeting-with-fda-for-primec-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2490558868","title":"BRIEF-Neurosense Receives Positive FDA Feedback On Phase 3 Study Design For Primec","url":"https://stock-news.laohu8.com/highlight/detail?id=2490558868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490558868?lang=en_us&edition=fundamental","pubTime":"2024-12-11 22:29","pubTimestamp":1733927362,"startTime":"0","endTime":"0","summary":"BRIEF-Neurosense Receives Positive FDA Feedback On Phase 3 Study Design For PrimecDec 11 (Reuters) - Neurosense Therapeutics NRSN.O:NEUROSENSE RECEIVES POSITIVE FDA FEEDBACK ON PHASE 3 STUDY DESIGN FO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2490850098","title":"Neurosense Receives Positive FDA Feedback on Phase 3 Study Design for Primec","url":"https://stock-news.laohu8.com/highlight/detail?id=2490850098","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490850098?lang=en_us&edition=fundamental","pubTime":"2024-12-11 22:25","pubTimestamp":1733927107,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2490850061","title":"Neurosense Therapeutics Ltd: Plans to Submit Final Protocol to FDA During First Half of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2490850061","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490850061?lang=en_us&edition=fundamental","pubTime":"2024-12-11 22:25","pubTimestamp":1733927107,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0NQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2490868310","title":"NeuroSense Receives Positive FDA Feedback on Phase 3 Study Design for PrimeC","url":"https://stock-news.laohu8.com/highlight/detail?id=2490868310","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490868310?lang=en_us&edition=fundamental","pubTime":"2024-12-11 22:25","pubTimestamp":1733927100,"startTime":"0","endTime":"0","summary":"The Type C meeting with the FDA, combined with the recent 18-month Phase 2b PARADIGM study readout, has the Company on track to commence a Phase 3 study in mid-2025. PrimeC has already demonstrated a significant impact on slowing disease progression and increasing survival rates in people living with ALS. Amyotrophic lateral sclerosis  is an incurable neurodegenerative disease that causes complete paralysis and death within 2-5 years from diagnosis. Every year, more than 5,000 people are diagnosed with ALS in the U.S. alone, with an annual disease burden of$1 billion. The number of people living with ALS is expected to g","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/t.bx.Ue6Dj8iT36MWBDTYw--~B/aD0xNjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/488fd1dd822c4adae2c61a5f94250e7d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/t.bx.Ue6Dj8iT36MWBDTYw--~B/aD0xNjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/488fd1dd822c4adae2c61a5f94250e7d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurosense-receives-positive-fda-feedback-142500846.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurosense-receives-positive-fda-feedback-142500846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","NRSN","NRSNW"],"gpt_icon":0},{"id":"2490088919","title":"Rimon Gold Assets Ltd. Reports  9.99% Passive Stake in Neurosense Therapeutics Ltd as of Dec 2 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2490088919","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490088919?lang=en_us&edition=fundamental","pubTime":"2024-12-10 05:02","pubTimestamp":1733778142,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2489262894","title":"NeuroSense Therapeutics Files Prospectus for Secondary Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2489262894","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489262894?lang=en_us&edition=fundamental","pubTime":"2024-12-07 06:03","pubTimestamp":1733522630,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics (NRSN) late Friday disclosed plans by one of its larger institutional investors to sell a portion of its stake in the biotechnology company from time to time.The company filed ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4139","NRSN"],"gpt_icon":0},{"id":"2488519905","title":"NeuroSense’s PrimeC Shows Promise in ALS Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2488519905","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488519905?lang=en_us&edition=fundamental","pubTime":"2024-12-04 21:58","pubTimestamp":1733320710,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd. (NRSN) has released an update. NeuroSense Therapeutics has announced promising results from its PARADIGM study, showin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurosenses-primec-shows-promise-in-als-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurosenses-primec-shows-promise-in-als-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2488199700","title":"NeuroSense announces ‘positive’ results from the PARADIGM study","url":"https://stock-news.laohu8.com/highlight/detail?id=2488199700","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488199700?lang=en_us&edition=fundamental","pubTime":"2024-12-04 21:41","pubTimestamp":1733319690,"startTime":"0","endTime":"0","summary":"NeuroSense (NRSN) Therapeutics is pleased to announce statistically significant positive results from the 18-month data analysis of the PARADIGM st...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurosense-announces-positive-results-from-the-paradigm-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurosense-announces-positive-results-from-the-paradigm-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2488199324","title":"NeuroSense Announces Completion of PARADIGM Study Highlighting PrimeC's Significant Efficacy and Survival Benefits in ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2488199324","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488199324?lang=en_us&edition=fundamental","pubTime":"2024-12-04 21:30","pubTimestamp":1733319000,"startTime":"0","endTime":"0","summary":"In participants who receivedPrimeC from the start of the 18-month study compared to those initially on placebo before transitioning to PrimeC, disease progression was slowed by 33% , demonstrated in a 58% improvement in survival rates. 8 points in ALSFRS-R between the group treated with PrimeC for 18 months and the group that received placebo for 6 months before transitioning to PrimeC for 12 months. This difference seen between the groups represents a. About ALSFRS-RDisease progression is measured by the ALS Functional Rating Scale-Revised , which is the most widely used ALS tracking tool accepted by the FDA, utilized by neurologists treating ALS patients, in clinical trials, and by other regulators to determine disease progression. It tracks 12 changes in a person's physical abilities over time including functions such as: speech, w","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/t.bx.Ue6Dj8iT36MWBDTYw--~B/aD0xNjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/488fd1dd822c4adae2c61a5f94250e7d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/t.bx.Ue6Dj8iT36MWBDTYw--~B/aD0xNjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/488fd1dd822c4adae2c61a5f94250e7d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurosense-announces-completion-paradigm-study-133000176.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurosense-announces-completion-paradigm-study-133000176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"NeuroSense Announces Completion of PARADIGM Study Highlighting PrimeC's Significant Efficacy and Survival Benefits in ALS","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NRSNW","NRSN"],"gpt_icon":0},{"id":"2488679655","title":"Neurosense Therapeutics Announces $5 Million Private Placement at Premium to Market Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2488679655","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488679655?lang=en_us&edition=fundamental","pubTime":"2024-12-02 21:30","pubTimestamp":1733146214,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nFWN3N30VB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2488921679","title":"Press Release: NeuroSense Therapeutics Announces $5 Million Private Placement at Premium to Market Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2488921679","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488921679?lang=en_us&edition=fundamental","pubTime":"2024-12-02 21:30","pubTimestamp":1733146200,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Dec. 2, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd.  , a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced the entry into a definitive agreement with a single investor and with NeuroSense's Chief Executive Officer, Mr. Alon Ben-Noon, to purchase an aggregate of $5,000,000 of ordinary shares  and warrants in a private placement, subject to certain closing conditions.In connection with the offering, NeuroSense agreed to sell an aggregate of 4,000,000 ordinary shares  and 8,000,000 warrants to purchase an aggregate of 8,000,000 ordinary shares, at a combined purchase price of $1.25 per share and two accompanying warrants, representing a purchase price of 25% above the closing pricing of NeuroSense's ordinary shares on November 29, 2024. The warrants have a term of five years from the date of issuance and an exercise price of $1.25 per share.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","LENZ","BK4139"],"gpt_icon":0},{"id":"2485929874","title":"NeuroSense Therapeutics to Participate in the 2024 International Symposium on ALS/MND","url":"https://stock-news.laohu8.com/highlight/detail?id=2485929874","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485929874?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:20","pubTimestamp":1732198800,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Nov. 21, 2024 /PRNewswire/ --NeuroSense Therapeutics Ltd. , a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, is pleased to announce its participation in the 2024 International Symposium on ALS/MND, to be held December 6-8, 2024, in Montreal, Canada.During the event, NeuroSense will present the latest findings from its Phase 2b PARADIGM trial of PrimeC, a potential treatment for Amyotrophic Lateral Sclerosis .Prof. Merit Cudkowicz, Chair of Neurology at Massachusetts General Hospital, Director of the Sean M. Healey & AMG Center for ALS, and the Julieanne Dorn Professor of Neurology at Harvard Medical School, will present the latest clinical outcomes from the PARADIGM trial. As a globally recognized leader in ALS research, Prof. Cudkowicz's insights into PrimeC's potential to improve patient outcomes are highly anticipated.Disease progression is measured by the ALS Functional Rating Scale-Revised , which is t","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/t.bx.Ue6Dj8iT36MWBDTYw--~B/aD0xNjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/488fd1dd822c4adae2c61a5f94250e7d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/t.bx.Ue6Dj8iT36MWBDTYw--~B/aD0xNjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/488fd1dd822c4adae2c61a5f94250e7d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurosense-therapeutics-participate-2024-international-142000609.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurosense-therapeutics-participate-2024-international-142000609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","NRSN","LU0054578231.USD","BK4161","NRSNW","LENZ","LU0053671581.USD","ITT"],"gpt_icon":1},{"id":"2484090402","title":"BRIEF-Neurosense Therapeutics Files For Offering Of Up To 10 Million Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2484090402","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484090402?lang=en_us&edition=fundamental","pubTime":"2024-11-20 06:25","pubTimestamp":1732055134,"startTime":"0","endTime":"0","summary":"BRIEF-Neurosense Therapeutics Files For Offering Of Up To 10 Million Ordinary SharesNov 19 (Reuters) - Neurosense Therapeutics Ltd NRSN.O:NEUROSENSE THERAPEUTICS LTD FILES FOR OFFERING OF UP TO 10 MILLION ORDINARY SHARESSource text: [https://tinyurl.com/my2bpjxj]Further company coverage: NRSN.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nFWN3MQ0YE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2484905503","title":"Neurosense Therapeutics Ltd Files for Offering of up to 10 Mln Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2484905503","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484905503?lang=en_us&edition=fundamental","pubTime":"2024-11-20 05:17","pubTimestamp":1732051023,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nFWN3MQ0YE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRSN","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRSN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-07","symbol":"NRSN","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743998400000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2024-12-18","symbol":"NRSN","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1734498000000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-06-24","symbol":"NRSN","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1719201600000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2024-04-05","symbol":"NRSN","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1712289600000,"reportTimeType":"pre","actualEps":-0.16},{"market":"US","date":"2023-11-28","symbol":"NRSN","fiscalQuarterEnding":"2023/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1701147600000,"reportTimeType":"pre","actualEps":0.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRSN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRSN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1734408000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NRSN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NRSN","date":"2025-04-23","current":-2.373022,"percent":0.358974,"low":-12.966568,"twenty":-3.471816,"median":-2.107553,"eighty":-1.389598,"high":-0.395084,"avg":-2.544273,"sd":1.73234,"marketCap":24228555},"quantilePoints":[{"date":"2021-12-10","current":-6.574093,"twenty":-10.190888,"median":-8.533367,"eighty":-7.593999,"marketCap":34566580},{"date":"2021-12-17","current":-6.369292,"twenty":-8.481481,"median":-7.033255,"eighty":-6.696973,"marketCap":33489739},{"date":"2021-12-23","current":-6.010892,"twenty":-7.839759,"median":-6.778893,"eighty":-6.385676,"marketCap":31605268},{"date":"2021-12-31","current":-5.03809,"twenty":-7.126398,"median":-6.420492,"eighty":-5.387602,"marketCap":26490276},{"date":"2022-01-07","current":-5.24289,"twenty":-6.939702,"median":-6.041612,"eighty":-5.268367,"marketCap":27567116},{"date":"2022-01-14","current":-5.632011,"twenty":-6.791181,"median":-5.652491,"eighty":-5.268367,"marketCap":29613113},{"date":"2022-01-21","current":-4.812809,"twenty":-6.737933,"median":-5.611531,"eighty":-5.166254,"marketCap":25305751},{"date":"2022-01-28","current":-3.829767,"twenty":-6.545421,"median":-5.509131,"eighty":-4.931594,"marketCap":20136917},{"date":"2022-02-04","current":-3.725547,"twenty":-6.426636,"median":-5.37601,"eighty":-4.251656,"marketCap":19588925},{"date":"2022-02-11","current":-3.663107,"twenty":-6.40206,"median":-5.24289,"eighty":-3.929516,"marketCap":19260619},{"date":"2022-02-18","current":-3.267658,"twenty":-6.303756,"median":-5.10977,"eighty":-3.725547,"marketCap":17181348},{"date":"2022-02-25","current":-3.14278,"twenty":-6.041612,"median":-5.01761,"eighty":-3.663107,"marketCap":16524736},{"date":"2022-03-04","current":-3.954491,"twenty":-6.010892,"median":-4.91521,"eighty":-3.683921,"marketCap":20792714},{"date":"2022-03-11","current":-2.934649,"twenty":-5.672971,"median":-4.706253,"eighty":-3.645447,"marketCap":15430382},{"date":"2022-03-18","current":-3.246845,"twenty":-5.652491,"median":-4.464649,"eighty":-3.267658,"marketCap":17071913},{"date":"2022-03-25","current":-8.783133,"twenty":-6.369292,"median":-4.706253,"eighty":-3.352784,"marketCap":46181713},{"date":"2022-04-01","current":-7.804917,"twenty":-6.778893,"median":-4.91521,"eighty":-3.579855,"marketCap":41038252},{"date":"2022-04-08","current":-5.89011,"twenty":-7.033255,"median":-5.04833,"eighty":-3.621481,"marketCap":30970201},{"date":"2022-04-14","current":-5.470413,"twenty":-6.846149,"median":-5.01761,"eighty":-3.640654,"marketCap":22105938},{"date":"2022-04-22","current":-6.4995,"twenty":-6.782989,"median":-5.16097,"eighty":-3.659575,"marketCap":26264481},{"date":"2022-04-29","current":-4.54965,"twenty":-6.615053,"median":-5.207035,"eighty":-3.663107,"marketCap":18385137},{"date":"2022-05-06","current":-4.197594,"twenty":-6.514419,"median":-5.05857,"eighty":-3.663107,"marketCap":16962477},{"date":"2022-05-13","current":-3.439319,"twenty":-6.444486,"median":-4.985732,"eighty":-3.653865,"marketCap":13898288},{"date":"2022-05-20","current":-4.073327,"twenty":-6.414348,"median":-4.894729,"eighty":-3.613156,"marketCap":16460316},{"date":"2022-05-27","current":-4.304438,"twenty":-6.377484,"median":-4.641324,"eighty":-3.640654,"marketCap":17394234},{"date":"2022-06-03","current":-3.629217,"twenty":-6.349925,"median":-4.548658,"eighty":-3.579438,"marketCap":16810535},{"date":"2022-06-10","current":-3.679623,"twenty":-6.207023,"median":-4.495488,"eighty":-3.604831,"marketCap":17044015},{"date":"2022-06-17","current":-4.183681,"twenty":-6.073112,"median":-4.437259,"eighty":-3.626123,"marketCap":19378811},{"date":"2022-06-24","current":-4.284493,"twenty":-6.029324,"median":-4.307067,"eighty":-3.635709,"marketCap":19845771},{"date":"2022-07-01","current":-8.316957,"twenty":-6.35638,"median":-4.441325,"eighty":-3.649036,"marketCap":38524143},{"date":"2022-07-08","current":-6.754377,"twenty":-6.429933,"median":-4.495488,"eighty":-3.65473,"marketCap":31286274},{"date":"2022-07-15","current":-5.191797,"twenty":-6.429933,"median":-4.548658,"eighty":-3.657397,"marketCap":24048404},{"date":"2022-07-22","current":-4.61213,"twenty":-6.423442,"median":-4.61213,"eighty":-3.663107,"marketCap":21363388},{"date":"2022-07-29","current":-4.712942,"twenty":-6.40206,"median":-4.762875,"eighty":-3.663107,"marketCap":21830348},{"date":"2022-08-05","current":-4.788551,"twenty":-6.362836,"median":-4.788551,"eighty":-3.66641,"marketCap":22180567},{"date":"2022-08-12","current":-5.368217,"twenty":-6.329755,"median":-4.80068,"eighty":-3.680483,"marketCap":24865583},{"date":"2022-08-19","current":-4.939768,"twenty":-6.265441,"median":-4.838957,"eighty":-3.683921,"marketCap":22881006},{"date":"2022-08-26","current":-5.04058,"twenty":-6.123516,"median":-4.892046,"eighty":-3.688102,"marketCap":23347966},{"date":"2022-09-02","current":-3.184552,"twenty":-6.104613,"median":-4.889362,"eighty":-3.680483,"marketCap":22881006},{"date":"2022-09-09","current":-3.265791,"twenty":-6.041612,"median":-4.838957,"eighty":-3.663107,"marketCap":23464705},{"date":"2022-09-16","current":-3.2008,"twenty":-6.023493,"median":-4.80068,"eighty":-3.629217,"marketCap":22997746},{"date":"2022-09-23","current":-2.599634,"twenty":-6.010892,"median":-4.738145,"eighty":-3.553609,"marketCap":18678372},{"date":"2022-09-30","current":-2.908341,"twenty":-5.930794,"median":-4.697946,"eighty":-3.4664,"marketCap":20896429},{"date":"2022-10-07","current":-2.745864,"twenty":-5.89011,"median":-4.61213,"eighty":-3.363277,"marketCap":19729031},{"date":"2022-10-14","current":-2.778359,"twenty":-5.822469,"median":-4.548658,"eighty":-3.298286,"marketCap":19962510},{"date":"2022-10-21","current":-2.518396,"twenty":-5.795388,"median":-4.495488,"eighty":-3.249543,"marketCap":18094673},{"date":"2022-10-28","current":-2.469653,"twenty":-5.741225,"median":-4.437259,"eighty":-3.184552,"marketCap":17744454},{"date":"2022-11-04","current":-2.420909,"twenty":-5.723606,"median":-4.304438,"eighty":-3.168304,"marketCap":17394234},{"date":"2022-11-11","current":-2.453405,"twenty":-5.672971,"median":-4.278838,"eighty":-3.11156,"marketCap":17627714},{"date":"2022-11-18","current":-3.005177,"twenty":-5.670652,"median":-4.198408,"eighty":-3.038323,"marketCap":21592198},{"date":"2022-11-25","current":-2.84335,"twenty":-5.656123,"median":-4.197594,"eighty":-2.986918,"marketCap":20429470},{"date":"2022-12-02","current":-2.117174,"twenty":-5.636107,"median":-4.157963,"eighty":-2.932864,"marketCap":19670661},{"date":"2022-12-09","current":-1.985243,"twenty":-5.599243,"median":-4.108073,"eighty":-2.912736,"marketCap":18444893},{"date":"2022-12-16","current":-1.758322,"twenty":-5.574667,"median":-4.076348,"eighty":-2.875845,"marketCap":16336571},{"date":"2022-12-23","current":-1.633428,"twenty":-5.521419,"median":-3.954491,"eighty":-2.820603,"marketCap":15176177},{"date":"2022-12-30","current":-1.532909,"twenty":-5.4859,"median":-3.928883,"eighty":-2.778359,"marketCap":14242259},{"date":"2023-01-06","current":-1.584048,"twenty":-5.469859,"median":-3.892052,"eighty":-2.752363,"marketCap":14717390},{"date":"2023-01-13","current":-1.696252,"twenty":-5.468686,"median":-3.836529,"eighty":-2.70362,"marketCap":15759877},{"date":"2023-01-20","current":-2.257227,"twenty":-5.456819,"median":-3.807103,"eighty":-2.664625,"marketCap":20971894},{"date":"2023-01-27","current":-2.143097,"twenty":-5.410473,"median":-3.730029,"eighty":-2.632,"marketCap":19911517},{"date":"2023-02-03","current":-2.067011,"twenty":-5.399028,"median":-3.715187,"eighty":-2.586636,"marketCap":19204599},{"date":"2023-02-10","current":-2.117735,"twenty":-5.363632,"median":-3.683921,"eighty":-2.56064,"marketCap":19675878},{"date":"2023-02-17","current":-2.472805,"twenty":-5.337817,"median":-3.663107,"eighty":-2.498898,"marketCap":22974827},{"date":"2023-02-24","current":-2.586934,"twenty":-5.307925,"median":-3.659538,"eighty":-2.469653,"marketCap":24035204},{"date":"2023-03-03","current":-2.181267,"twenty":-5.306583,"median":-3.645447,"eighty":-2.421072,"marketCap":20266154},{"date":"2023-03-10","current":-2.168459,"twenty":-5.292609,"median":-3.600668,"eighty":-2.384037,"marketCap":20147156},{"date":"2023-03-17","current":-2.29527,"twenty":-5.24289,"median":-3.553609,"eighty":-2.307663,"marketCap":21325353},{"date":"2023-03-24","current":-1.662583,"twenty":-5.226682,"median":-3.507022,"eighty":-2.269908,"marketCap":20516275},{"date":"2023-03-31","current":-1.643473,"twenty":-5.217,"median":-3.439319,"eighty":-2.231865,"marketCap":20280456},{"date":"2023-04-06","current":-1.624363,"twenty":-5.196838,"median":-3.395772,"eighty":-2.206503,"marketCap":20044637},{"date":"2023-04-14","current":-1.595698,"twenty":-5.188271,"median":-3.35543,"eighty":-2.181242,"marketCap":19690908},{"date":"2023-04-21","current":-1.834574,"twenty":-5.170753,"median":-3.298286,"eighty":-2.165923,"marketCap":22638648},{"date":"2023-04-28","current":-1.815464,"twenty":-5.162095,"median":-3.266725,"eighty":-2.132364,"marketCap":22402829},{"date":"2023-05-05","current":-1.663852,"twenty":-5.104983,"median":-3.246845,"eighty":-2.105764,"marketCap":20531935},{"date":"2023-05-12","current":-1.663852,"twenty":-5.090986,"median":-3.192676,"eighty":-2.067939,"marketCap":20531935},{"date":"2023-05-19","current":-1.635165,"twenty":-5.090986,"median":-3.184406,"eighty":-2.021262,"marketCap":20177936},{"date":"2023-05-26","current":-1.577791,"twenty":-5.070824,"median":-3.160181,"eighty":-1.98273,"marketCap":19469938},{"date":"2023-05-30","current":-1.529979,"twenty":-5.065783,"median":-3.152057,"eighty":-1.972678,"marketCap":18879940},{"date":"2023-06-09","current":-1.667747,"twenty":-5.05857,"median":-3.123684,"eighty":-1.940201,"marketCap":22537929},{"date":"2023-06-16","current":-1.606625,"twenty":-5.04058,"median":-3.08034,"eighty":-1.922419,"marketCap":21711931},{"date":"2023-06-23","current":-1.397065,"twenty":-5.04058,"median":-3.038323,"eighty":-1.882,"marketCap":18879940},{"date":"2023-06-30","current":-1.257359,"twenty":-5.04058,"median":-2.989579,"eighty":-1.815464,"marketCap":16991946},{"date":"2023-07-07","current":-1.340783,"twenty":-5.039584,"median":-2.976275,"eighty":-1.751128,"marketCap":18119348},{"date":"2023-07-14","current":-1.331068,"twenty":-5.029005,"median":-2.934649,"eighty":-1.709433,"marketCap":17988049},{"date":"2023-07-21","current":-1.388002,"twenty":-5.015377,"median":-2.924589,"eighty":-1.68025,"marketCap":18757465},{"date":"2023-07-28","current":-1.32057,"twenty":-5.008078,"median":-2.911088,"eighty":-1.663852,"marketCap":17846185},{"date":"2023-08-04","current":-1.02823,"twenty":-4.994348,"median":-2.893022,"eighty":-1.662583,"marketCap":13895502},{"date":"2023-08-11","current":-1.018149,"twenty":-4.983838,"median":-2.859598,"eighty":-1.65429,"marketCap":13759272},{"date":"2023-08-18","current":-0.785704,"twenty":-4.970589,"median":-2.827102,"eighty":-1.643975,"marketCap":11988276},{"date":"2023-08-25","current":-0.803651,"twenty":-4.964971,"median":-2.794607,"eighty":-1.64232,"marketCap":12262100},{"date":"2023-09-01","current":-0.839275,"twenty":-4.95489,"median":-2.778359,"eighty":-1.635165,"marketCap":12805659},{"date":"2023-09-08","current":-0.832936,"twenty":-4.939768,"median":-2.762111,"eighty":-1.633428,"marketCap":12708935},{"date":"2023-09-15","current":-0.76508,"twenty":-4.939768,"median":-2.737821,"eighty":-1.624363,"marketCap":11673584},{"date":"2023-09-22","current":-0.785526,"twenty":-4.939768,"median":-2.697121,"eighty":-1.608262,"marketCap":11985552},{"date":"2023-09-29","current":-0.669634,"twenty":-4.934856,"median":-2.664625,"eighty":-1.59597,"marketCap":10217281},{"date":"2023-10-06","current":-0.521511,"twenty":-4.911114,"median":-2.63213,"eighty":-1.584467,"marketCap":7957218},{"date":"2023-10-13","current":-0.508922,"twenty":-4.893656,"median":-2.599634,"eighty":-1.571801,"marketCap":7765133},{"date":"2023-10-20","current":-0.482315,"twenty":-4.889362,"median":-2.586934,"eighty":-1.557715,"marketCap":7359167},{"date":"2023-10-27","current":-0.420977,"twenty":-4.889362,"median":-2.583386,"eighty":-1.550731,"marketCap":6423264},{"date":"2023-11-03","current":-0.427673,"twenty":-4.859119,"median":-2.575182,"eighty":-1.529941,"marketCap":6525437},{"date":"2023-11-10","current":-0.473207,"twenty":-4.838957,"median":-2.534643,"eighty":-1.428226,"marketCap":7220198},{"date":"2023-11-17","current":-0.458923,"twenty":-4.823268,"median":-2.50621,"eighty":-1.39344,"marketCap":7002243},{"date":"2023-11-24","current":-0.573296,"twenty":-4.803106,"median":-2.471229,"eighty":-1.365256,"marketCap":8747355},{"date":"2023-12-01","current":-1.530812,"twenty":-4.788551,"median":-2.434888,"eighty":-1.354573,"marketCap":17573724},{"date":"2023-12-08","current":-0.947576,"twenty":-4.768389,"median":-2.421072,"eighty":-1.344766,"marketCap":10878169},{"date":"2023-12-15","current":-1.035548,"twenty":-4.728064,"median":-2.409536,"eighty":-1.33788,"marketCap":11888089},{"date":"2023-12-22","current":-0.924958,"twenty":-4.712942,"median":-2.352334,"eighty":-1.320883,"marketCap":10618514},{"date":"2023-12-29","current":-0.928529,"twenty":-4.712942,"median":-2.34536,"eighty":-1.310489,"marketCap":10659512},{"date":"2024-01-05","current":-0.929719,"twenty":-4.694947,"median":-2.307807,"eighty":-1.276215,"marketCap":10673178},{"date":"2024-01-12","current":-1.105068,"twenty":-4.65558,"median":-2.29527,"eighty":-1.218395,"marketCap":12686186},{"date":"2024-01-19","current":-1.130782,"twenty":-4.627252,"median":-2.269908,"eighty":-1.115354,"marketCap":12981373},{"date":"2024-01-26","current":-1.226134,"twenty":-4.607157,"median":-2.231865,"eighty":-1.134639,"marketCap":14076023},{"date":"2024-02-02","current":-1.541596,"twenty":-4.579679,"median":-2.219184,"eighty":-1.141376,"marketCap":17697524},{"date":"2024-02-09","current":-1.571357,"twenty":-4.548856,"median":-2.206503,"eighty":-1.166661,"marketCap":18039175},{"date":"2024-02-16","current":-1.583261,"twenty":-4.543502,"median":-2.181267,"eighty":-1.20534,"marketCap":18175835},{"date":"2024-02-23","current":-1.499931,"twenty":-4.528904,"median":-2.18114,"eighty":-1.210592,"marketCap":17219212},{"date":"2024-03-01","current":-2.107047,"twenty":-4.48932,"median":-2.162119,"eighty":-1.21423,"marketCap":24188894},{"date":"2024-03-08","current":-2.392748,"twenty":-4.459984,"median":-2.18114,"eighty":-1.214653,"marketCap":27468744},{"date":"2024-03-15","current":-1.654686,"twenty":-4.439699,"median":-2.162119,"eighty":-1.217027,"marketCap":18995798},{"date":"2024-03-22","current":-2.154663,"twenty":-4.408494,"median":-2.143097,"eighty":-1.221037,"marketCap":24735536},{"date":"2024-03-28","current":-2.05943,"twenty":-4.309696,"median":-2.142759,"eighty":-1.226134,"marketCap":23642252},{"date":"2024-04-05","current":-2.452269,"twenty":-4.304438,"median":-2.155221,"eighty":-1.239925,"marketCap":28152046},{"date":"2024-04-12","current":-2.323708,"twenty":-4.284493,"median":-2.154663,"eighty":-1.257359,"marketCap":26211430},{"date":"2024-04-19","current":-2.102403,"twenty":-4.278838,"median":-2.155221,"eighty":-1.270167,"marketCap":23715103},{"date":"2024-04-26","current":-1.936249,"twenty":-4.278838,"median":-2.143097,"eighty":-1.279703,"marketCap":21840892},{"date":"2024-05-03","current":-1.951616,"twenty":-4.234087,"median":-2.139758,"eighty":-1.280247,"marketCap":22014233},{"date":"2024-05-10","current":-1.803785,"twenty":-4.198408,"median":-2.130855,"eighty":-1.285655,"marketCap":20346698},{"date":"2024-05-17","current":-1.874781,"twenty":-4.197795,"median":-2.117455,"eighty":-1.309749,"marketCap":21147531},{"date":"2024-05-24","current":-1.789876,"twenty":-4.197594,"median":-2.10806,"eighty":-1.310489,"marketCap":20189806},{"date":"2024-05-31","current":-1.726947,"twenty":-4.186464,"median":-2.105942,"eighty":-1.311407,"marketCap":19479966},{"date":"2024-06-07","current":-1.822889,"twenty":-4.163519,"median":-2.098772,"eighty":-1.318783,"marketCap":20562186},{"date":"2024-06-14","current":-1.631006,"twenty":-4.15786,"median":-2.091146,"eighty":-1.321039,"marketCap":18397746},{"date":"2024-06-21","current":-1.439123,"twenty":-4.147779,"median":-2.079191,"eighty":-1.321352,"marketCap":16233305},{"date":"2024-06-28","current":-1.461647,"twenty":-4.13811,"median":-2.074553,"eighty":-1.321352,"marketCap":18397746},{"date":"2024-07-05","current":-1.891543,"twenty":-4.118154,"median":-2.071187,"eighty":-1.327182,"marketCap":23808847},{"date":"2024-07-12","current":-1.475976,"twenty":-4.103339,"median":-2.059598,"eighty":-1.33212,"marketCap":18578116},{"date":"2024-07-15","current":-1.447317,"twenty":-4.101761,"median":-2.059514,"eighty":-1.33247,"marketCap":18217376},{"date":"2024-08-02","current":-0.974431,"twenty":-4.100183,"median":-2.05943,"eighty":-1.331068,"marketCap":12265164},{"date":"2024-08-09","current":-0.899916,"twenty":-4.07937,"median":-2.045943,"eighty":-1.311636,"marketCap":11327239},{"date":"2024-08-16","current":-1.06041,"twenty":-4.073327,"median":-2.025676,"eighty":-1.280247,"marketCap":13347384},{"date":"2024-08-23","current":-1.279298,"twenty":-3.986661,"median":-2.00107,"eighty":-1.257359,"marketCap":16102521},{"date":"2024-08-30","current":-1.175655,"twenty":-3.954491,"median":-1.988004,"eighty":-1.251453,"marketCap":14797964},{"date":"2024-09-06","current":-1.469568,"twenty":-3.93622,"median":-1.985243,"eighty":-1.252691,"marketCap":18497455},{"date":"2024-09-13","current":-1.995519,"twenty":-3.929437,"median":-1.982351,"eighty":-1.255411,"marketCap":25117597},{"date":"2024-09-20","current":-2.088334,"twenty":-3.927201,"median":-1.988004,"eighty":-1.25709,"marketCap":26285858},{"date":"2024-09-27","current":-1.964581,"twenty":-3.898998,"median":-1.986624,"eighty":-1.267605,"marketCap":24728177},{"date":"2024-10-04","current":-2.424436,"twenty":-3.875294,"median":-1.988004,"eighty":-1.277472,"marketCap":23754627},{"date":"2024-10-11","current":-2.424436,"twenty":-3.847995,"median":-1.99449,"eighty":-1.279622,"marketCap":23754627},{"date":"2024-10-18","current":-2.185967,"twenty":-3.833116,"median":-1.995519,"eighty":-1.280138,"marketCap":21418106},{"date":"2024-10-25","current":-2.404564,"twenty":-3.829982,"median":-2.003739,"eighty":-1.283201,"marketCap":23559917},{"date":"2024-10-31","current":-2.583416,"twenty":-3.80257,"median":-2.017353,"eighty":-1.284969,"marketCap":25312307},{"date":"2024-11-08","current":-2.563543,"twenty":-3.761592,"median":-2.035308,"eighty":-1.300111,"marketCap":25117597},{"date":"2024-11-15","current":-2.583416,"twenty":-3.736561,"median":-2.053627,"eighty":-1.310193,"marketCap":25312307},{"date":"2024-11-22","current":-1.828263,"twenty":-3.72734,"median":-2.059186,"eighty":-1.311177,"marketCap":17913325},{"date":"2024-11-29","current":-1.947697,"twenty":-3.725547,"median":-2.043819,"eighty":-1.31521,"marketCap":19083532},{"date":"2024-12-06","current":-2.066733,"twenty":-3.717259,"median":-2.053627,"eighty":-1.320883,"marketCap":20249846},{"date":"2024-12-13","current":-1.848136,"twenty":-3.696464,"median":-2.043819,"eighty":-1.321352,"marketCap":18108035},{"date":"2024-12-20","current":-2.149266,"twenty":-3.683921,"median":-2.039563,"eighty":-1.325238,"marketCap":24922887},{"date":"2024-12-27","current":-2.169482,"twenty":-3.683061,"median":-2.053627,"eighty":-1.331419,"marketCap":25157314},{"date":"2025-01-03","current":-2.293458,"twenty":-3.679623,"median":-2.059514,"eighty":-1.332821,"marketCap":26594934},{"date":"2025-01-10","current":-2.22944,"twenty":-3.66641,"median":-2.066733,"eighty":-1.335319,"marketCap":25852588},{"date":"2025-01-17","current":-2.233628,"twenty":-3.663107,"median":-2.066733,"eighty":-1.339815,"marketCap":25901153},{"date":"2025-01-24","current":-2.253571,"twenty":-3.663107,"median":-2.067011,"eighty":-1.340783,"marketCap":26132413},{"date":"2025-01-31","current":-2.11397,"twenty":-3.658824,"median":-2.072865,"eighty":-1.340783,"marketCap":24513591},{"date":"2025-02-07","current":-2.357276,"twenty":-3.65504,"median":-2.074083,"eighty":-1.34088,"marketCap":27334967},{"date":"2025-02-14","current":-2.333344,"twenty":-3.649036,"median":-2.074377,"eighty":-1.346677,"marketCap":27057455},{"date":"2025-02-21","current":-2.193742,"twenty":-3.638955,"median":-2.079191,"eighty":-1.350624,"marketCap":25438633},{"date":"2025-02-28","current":-2.133913,"twenty":-3.626123,"median":-2.088334,"eighty":-1.354573,"marketCap":24744852},{"date":"2025-03-07","current":-2.309213,"twenty":-3.604831,"median":-2.091146,"eighty":-1.360215,"marketCap":26777630},{"date":"2025-03-14","current":-2.243568,"twenty":-3.579438,"median":-2.094026,"eighty":-1.360985,"marketCap":26016413},{"date":"2025-03-21","current":-2.1382,"twenty":-3.568731,"median":-2.103728,"eighty":-1.365256,"marketCap":24794571},{"date":"2025-03-28","current":-2.083313,"twenty":-3.543528,"median":-2.105942,"eighty":-1.37266,"marketCap":24158098},{"date":"2025-04-04","current":-1.897978,"twenty":-3.525269,"median":-2.098772,"eighty":-1.378473,"marketCap":22008957},{"date":"2025-04-11","current":-2.322998,"twenty":-3.50973,"median":-2.102403,"eighty":-1.383833,"marketCap":23717812},{"date":"2025-04-17","current":-2.422362,"twenty":-3.488065,"median":-2.105942,"eighty":-1.388401,"marketCap":24732317},{"date":"2025-04-23","current":-2.373022,"twenty":-3.471816,"median":-2.107553,"eighty":-1.389598,"marketCap":24228555}],"updateTime":1745493548632}}}